Subscribe
Generic selectors
Exact matches only
Search in title
Search in content
Post Type Selectors

Archive

European approval for Itulazax (tree pollen sublingual allergy immunotherapy tablet) for treatment of young children and adolescents – ALK

Written by | 5 Jun 2025

ALK-Abello announced that its European regulatory filing for Itulazax (tree pollen sublingual allergy immunotherapy tablet) for treatment of young children and adolescents aged five to 17 has been… read more.

NICE (UK) positive for Acarizax (12 SQ-HDM SLIT) for moderate to severe house dust mite allergic rhinitis – ALK

Written by | 29 Mar 2025

NICE (UK): 12 standard quality house dust mite sublingual lyophilisate (SQ-HDM SLIT) is recommended, within its marketing authorisation, as an option for treating moderate to severe house dust mite… read more.

Newsletter Icon

Subscribe for our mailing list

If you're a healthcare professional you can sign up to our mailing list to receive high quality medical, pharmaceutical and healthcare E-Mails and E-Journals. Get the latest news and information across a broad range of specialities delivered straight to your inbox.

Subscribe

You can unsubscribe at any time using the 'Unsubscribe' link at the bottom of all our E-Mails, E-Journals and publications.